ABCL
Price
$2.01
Change
-$0.00 (-0.00%)
Updated
May 8 closing price
Capitalization
599.83M
95 days until earnings call
ATAI
Price
$1.40
Change
+$0.01 (+0.72%)
Updated
May 8 closing price
Capitalization
277.72M
11 days until earnings call
Ad is loading...

ABCL vs ATAI

Header iconABCL vs ATAI Comparison
Open Charts ABCL vs ATAIBanner chart's image
AbCellera Biologics
Price$2.01
Change-$0.00 (-0.00%)
Volume$6.03M
Capitalization599.83M
ATAI Life Sciences
Price$1.40
Change+$0.01 (+0.72%)
Volume$1.39M
Capitalization277.72M
ABCL vs ATAI Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. ATAI commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ATAI is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ABCL: $2.01 vs. ATAI: $1.40)
Brand notoriety: ABCL and ATAI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 148% vs. ATAI: 85%
Market capitalization -- ABCL: $599.83M vs. ATAI: $277.72M
ABCL [@Biotechnology] is valued at $599.83M. ATAI’s [@Biotechnology] market capitalization is $277.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileATAI’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ATAI’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABCL and ATAI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while ATAI’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 7 bearish.
  • ATAI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -19.28% price change this week, while ATAI (@Biotechnology) price change was -4.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

ATAI is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($600M) has a higher market cap than ATAI($278M). ATAI YTD gains are higher at: 5.263 vs. ABCL (-31.399). ATAI has higher annual earnings (EBITDA): -124.33M vs. ABCL (-204.15M). ABCL has more cash in the bank: 626M vs. ATAI (85.9M). ATAI has less debt than ABCL: ATAI (23.8M) vs ABCL (65.4M). ABCL has higher revenues than ATAI: ABCL (28.8M) vs ATAI (331K).
ABCLATAIABCL / ATAI
Capitalization600M278M216%
EBITDA-204.15M-124.33M164%
Gain YTD-31.3995.263-597%
P/E RatioN/AN/A-
Revenue28.8M331K8,701%
Total Cash626M85.9M729%
Total Debt65.4M23.8M275%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
70

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLATAI
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 16 days ago
76%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SNTCX23.59N/A
N/A
Steward International Enhanced Index I
SWHFX23.31N/A
N/A
Schwab Health Care
PLGIX15.80N/A
N/A
Principal LargeCap Growth I Instl
NSRIX22.46N/A
N/A
Northern World Selection Index I
GMEPX23.12N/A
N/A
Goldman Sachs China Equity P

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
N/A
CRSP - ABCL
62%
Loosely correlated
+5.52%
ABSI - ABCL
59%
Loosely correlated
+5.26%
RXRX - ABCL
58%
Loosely correlated
+4.77%
NTLA - ABCL
58%
Loosely correlated
+13.58%
BEAM - ABCL
57%
Loosely correlated
+6.32%
More